Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Engelen

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Acta Clinica Belgica|January 1, 1996
Epidemiology of microalbuminuria in type 1 diabetic patients (IDDM) in the Antwerp University HospitalA Bouten, W Engelen, I De Leeuw
Acta Clinica Belgica|January 1, 1994
Insulin antibodies before and 1 year after the change-over from U40 to U100 insulin preparations in BelgiumW Engelen, L Van Gaal, I De Leeuw
Chemical Communications (Cambridge, England)|January 27, 2016
DNA-based control of protein activityW Engelen, B M G Janssen, M Merkx
Magnesium Research|June 1, 1997
Effect of intensive i.v. + oral magnesium supplementation on circulating ion levels, lipid parameters and metabolic control in Mg-depleted insulin-dependent diabetic patients (IDDM)I De Leeuw, W Engelen, J Vertommen, et al.
Magnesium Research|November 4, 1998
Effect of intensive magnesium supplementation on the in vitro oxidizability of LDL and VLDL in Mg-depleted type 1 diabetic patientsI De Leeuw, W Engelen, P Aerts, et al.
The American Journal of Clinical Nutrition|November 4, 2000
Effects of long-term supplementation with moderate pharmacologic doses of vitamin E are saturable and reversible in patients with type 1 diabetesW Engelen, B M Keenoy, J Vertommen, et al.
Magnesium Research|September 29, 2000
Are low magnesium levels in type 1 diabetes associated with electromyographical signs of polyneuropathy?W Engelen, A Bouten, I De Leeuw, et al.
Diabetes & Metabolism|June 17, 2005
Effects of micronized fenofibrate and vitamin E on in vitro oxidation of lipoproteins in patients with type 1 diabetes mellitusW Engelen, B Manuel-y-Keenoy, J Vertommen, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 26, 2003
[Nephrogenic fibrosing dermopathy]J W Engelen, M P Kooistra, M R Canninga-van Dijk, et al.
The Journal of Nutrition|June 1, 2001
Long-term pharmacologic doses of vitamin E only moderately affect the erythrocytes of patients with type 1 diabetes mellitusB Manuel y Keenoy, H Shen, W Engelen, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Acta Clinica Belgica|January 1, 1996
Epidemiology of microalbuminuria in type 1 diabetic patients (IDDM) in the Antwerp University HospitalA Bouten, W Engelen, I De Leeuw
Acta Clinica Belgica|January 1, 1994
Insulin antibodies before and 1 year after the change-over from U40 to U100 insulin preparations in BelgiumW Engelen, L Van Gaal, I De Leeuw
Chemical Communications (Cambridge, England)|January 27, 2016
DNA-based control of protein activityW Engelen, B M G Janssen, M Merkx
Magnesium Research|June 1, 1997
Effect of intensive i.v. + oral magnesium supplementation on circulating ion levels, lipid parameters and metabolic control in Mg-depleted insulin-dependent diabetic patients (IDDM)I De Leeuw, W Engelen, J Vertommen, et al.
Magnesium Research|November 4, 1998
Effect of intensive magnesium supplementation on the in vitro oxidizability of LDL and VLDL in Mg-depleted type 1 diabetic patientsI De Leeuw, W Engelen, P Aerts, et al.
The American Journal of Clinical Nutrition|November 4, 2000
Effects of long-term supplementation with moderate pharmacologic doses of vitamin E are saturable and reversible in patients with type 1 diabetesW Engelen, B M Keenoy, J Vertommen, et al.
Magnesium Research|September 29, 2000
Are low magnesium levels in type 1 diabetes associated with electromyographical signs of polyneuropathy?W Engelen, A Bouten, I De Leeuw, et al.
Diabetes & Metabolism|June 17, 2005
Effects of micronized fenofibrate and vitamin E on in vitro oxidation of lipoproteins in patients with type 1 diabetes mellitusW Engelen, B Manuel-y-Keenoy, J Vertommen, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 26, 2003
[Nephrogenic fibrosing dermopathy]J W Engelen, M P Kooistra, M R Canninga-van Dijk, et al.
The Journal of Nutrition|June 1, 2001
Long-term pharmacologic doses of vitamin E only moderately affect the erythrocytes of patients with type 1 diabetes mellitusB Manuel y Keenoy, H Shen, W Engelen, et al.
Pageof 2